<code id='E0B46927A9'></code><style id='E0B46927A9'></style>
    • <acronym id='E0B46927A9'></acronym>
      <center id='E0B46927A9'><center id='E0B46927A9'><tfoot id='E0B46927A9'></tfoot></center><abbr id='E0B46927A9'><dir id='E0B46927A9'><tfoot id='E0B46927A9'></tfoot><noframes id='E0B46927A9'>

    • <optgroup id='E0B46927A9'><strike id='E0B46927A9'><sup id='E0B46927A9'></sup></strike><code id='E0B46927A9'></code></optgroup>
        1. <b id='E0B46927A9'><label id='E0B46927A9'><select id='E0B46927A9'><dt id='E0B46927A9'><span id='E0B46927A9'></span></dt></select></label></b><u id='E0B46927A9'></u>
          <i id='E0B46927A9'><strike id='E0B46927A9'><tt id='E0B46927A9'><pre id='E0B46927A9'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:3
          Empty intravenous pole
          Adobe

          WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies.

          The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages. Fifty-seven percent of hospital pharmacists said they are facing critical shortages of chemotherapy drugs in a new survey from the American Society of Health-System Pharmacists. Hospital pharmacists also reported significant shortages of steroids, hormonal drugs, and oral liquids such as amoxicillin and lidocaine.

          advertisement

          Yet industry and patient representatives who have met with task force members said there has been no indication of when they will make recommendations that could spur federal agencies to act and steer the debate in Congress.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Death of patient in Alzheimer’s trial raises question of possible risks
          Death of patient in Alzheimer’s trial raises question of possible risks

          APSTockTheexperimentalAlzheimer’sdruglecanemab,hailedafteritslowedpatients’cognitivedeclineinaclinic

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Medicare Advantage today, explained in one chart

          PabloMartinezMonsivais/APYou’rereadingthewebversionofHealthCareInc., STAT’sweeklynewsletter followin